Expert: Author Services
Duncan MacRae is the Director, Editorial Strategy and Publishing Policy for Wolters Kluwer, one of the world’s foremost publishers of medical, nursing and allied health journals. In this role, Duncan oversees the development and implementation of editorial policies followed by journals in the Lippincott and Medknow imprints. In addition, he works with a portfolio of editorial service providers to assist our society partners in achieving their strategic goals.
Prior to joining Wolters Kluwer Health, Duncan established a 15-year career, providing editorial management for the Congress of Neurological Surgeons, PriMed and the International Congress of Neuropathology.
What Oncology journals do you read on a regular basis?
Article Processing Charge (APC) Waiver Requests
What can we do to help you?
Recent Comments
Everything you have written is phenomenal, absolutely everything. However, why have prestigious journals with high-impact indexes been inclined to launch “open access” publications as well? In my opinion, as a full professor of medicine, the field of medicine is becoming increasingly commercialized every day. The trend seems to be that the more you pay, the more you get published.
Many societies are launching open access "spin-off" journals because the rejection rate of their primary journal is so high they have enough quality content to populate a second journal. Most journals will offer a direct transfer of quality rejects to the open access spin-off journal - sometimes without additional review, so authors benefit from not having to take the time submitting their rejected manuscript to an entirely new journal at a different society/publisher.
Using the open access model greatly reduces the costs of a journal launch (and subsequent risk) by eliminating the need for lining up subscribers and advertisers - in the eyes of the society, they are providing authors an opportunity to publish with an affiliation to the prestigious journal. It should be noted that the fees for most open access spin-off journals are substantially lower than the fees associated with publishing an open access article in a subscription journal (ie, the hybrid model).
Overall - it is about offering more options to authors, keeping quality content within the society's ecosystem, and generating additional income to offset the loss of print advertising revenue that has occurred as readers opt for online consumption of content.
What's next? It seems that Clarivate has been making some massive changes to their Impact Factor in the last couple of years. Does this make anyone else want to look at other metrics to gauge the impact of a journal?
One of the reasons for all the changes is to encourage the use of other metrics, specifically Journal Citation Indicator (JCI), a metric Clarivate introduced in 2017.
Congratulations!
Congratulations!
Congratulations!
Congratulations. Could you share with the community why you chose to submit to the International Journal of Urology over other journals, and what your peer review experience was like?
Welcome!
Welcome!